1. Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma
   Joel Isohookana et al, 2018, Pathology - Research and Practice CrossRef
2. Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine
   Hari Shanker Sharma et al, 2020, Novel Therapeutic Advances in Glioblastoma CrossRef
3. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas
   Shalini Sundramurthi Chelliah et al, 2021, Molecules CrossRef
4. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions
   Karin Jasek et al, 2019, Biomolecules CrossRef
5. Advances in enzyme-free nucleic acid amplification-based fluorescent biosensors for real-time imaging of DNA repair enzymes in living cells
   Qian Zhang et al, 2023, Coordination Chemistry Reviews CrossRef
6. Temozolomide Therapy in Management of Refractory Pituitary Adenomas: A Case Series of 39 Patients
   Xiaohai Liu et al, 2024, Endocrine Practice CrossRef
7. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
   Manendra Singh Tomar et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
8. A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care
   Ahmed Habib et al, 2021, Journal of Neuro-Oncology CrossRef
9. Profiling demethylase activity using epigenetically inactivated DNAzyme
   Juan Huang et al, 2022, Biosensors and Bioelectronics CrossRef
10. Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression
    Mohammed A. Ibrahim Al-Obaide et al, 2021, International Journal of Molecular Sciences CrossRef
11. Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond
    S. Daisy Precilla et al, 2021, Cell Biology International CrossRef
12. MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas
    Elies Fuster-Garcia et al, 2021, European Radiology CrossRef
13. Prognostic significance of MGMT promoter methylation in diffuse glioma patients
    Nikola Jovanović et al, 2019, Biotechnology & Biotechnological Equipment CrossRef
14. A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology
    Mahdi Abdoli Shadbad et al, 2021, Frontiers in Immunology CrossRef
15. The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma
    Qiong Wu et al, 2024, Cells CrossRef
16. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme
    Janaki Ramaiah Mekala et al, 2023, Metabolic Brain Disease CrossRef